These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 8808871

  • 21. Prostate-specific antigen (PSA) complexed to alpha1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL.
    Kobayashi T, Kamoto T, Nishizawa K, Mitsumori K, Ogura K, Ide Y.
    BJU Int; 2005 Apr; 95(6):761-5. PubMed ID: 15794778
    [Abstract] [Full Text] [Related]

  • 22. Free/total prostate-specific antigen ratio--hope and controversies.
    Ravery V, Boccon-Gibod L.
    Eur Urol; 1997 Apr; 31(4):385-8. PubMed ID: 9187894
    [Abstract] [Full Text] [Related]

  • 23. Prostate specific antigen in benign prostatic hyperplasia: purification and characterization.
    Chen Z, Chen H, Stamey TA.
    J Urol; 1997 Jun; 157(6):2166-70. PubMed ID: 9146608
    [Abstract] [Full Text] [Related]

  • 24. Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum.
    Lilja H, Cockett AT, Abrahamsson PA.
    Cancer; 1992 Jul 01; 70(1 Suppl):230-4. PubMed ID: 1376193
    [Abstract] [Full Text] [Related]

  • 25. Production, analysis, and characterization of reference materials for prostate-specific antigen.
    Garg UC, Howanitz JH, Nakamura RM, Plous RH, Eckfeldt JH.
    Arch Pathol Lab Med; 1995 Dec 01; 119(12):1104-8. PubMed ID: 7503657
    [Abstract] [Full Text] [Related]

  • 26. Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.
    Lilja H, Haese A, Björk T, Friedrich MG, Piironen T, Pettersson K, Huland E, Huland H.
    J Urol; 1999 Dec 01; 162(6):2029-34; discussion 2034-5. PubMed ID: 10569562
    [Abstract] [Full Text] [Related]

  • 27. PSA forms complexes with α1-antichymotrypsin in prostate.
    Zhu L, Jäämaa S, Af Hällström TM, Laiho M, Sankila A, Nordling S, Stenman UH, Koistinen H.
    Prostate; 2013 Jan 01; 73(2):219-26. PubMed ID: 22806587
    [Abstract] [Full Text] [Related]

  • 28. The release of free prostate specific antigen into the circulation during transurethral resection of the prostate: kinetics and interaction with serum protease inhibitors.
    Coker CB, Coptcoat MJ, Mulvin D, Cuomo A, Scott N, Sherwood R.
    Br J Urol; 1998 Jan 01; 81(1):105-8. PubMed ID: 9467485
    [Abstract] [Full Text] [Related]

  • 29. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
    Michel S, Charrier JP, Deleage G, Battail-Poirot N, Jolivet M, Jolivet-Reynaud C.
    J Urol; 2001 Jan 01; 165(1):301-6. PubMed ID: 11125429
    [Abstract] [Full Text] [Related]

  • 30. Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulin.
    España F, Sánchez-Cuenca J, Estellés A, Gilabert J, Griffin JH, Heeb MJ.
    Clin Chem; 1996 Apr 01; 42(4):545-50. PubMed ID: 8605671
    [Abstract] [Full Text] [Related]

  • 31. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach.
    Tajiri M, Ohyama C, Wada Y.
    Glycobiology; 2008 Jan 01; 18(1):2-8. PubMed ID: 17956937
    [Abstract] [Full Text] [Related]

  • 32. Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.
    Nakano Y, Okamura K, Takamura S, Okamoto N, Narishima M, Yoshino Y, Hattori R, Ono Y, Ohshima S, Nagasaka T.
    Int J Urol; 2005 Aug 01; 12(8):721-7. PubMed ID: 16174045
    [Abstract] [Full Text] [Related]

  • 33. Clearance mechanism of prostate specific antigen and its complexes with alpha2-macroglobulin and alpha1-antichymotrypsin.
    Birkenmeier G, Struck F, Gebhardt R.
    J Urol; 1999 Sep 01; 162(3 Pt 1):897-901. PubMed ID: 10458404
    [Abstract] [Full Text] [Related]

  • 34. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells.
    Väisänen V, Lövgren J, Hellman J, Piironen T, Lilja H, Pettersson K.
    Prostate Cancer Prostatic Dis; 1999 Mar 01; 2(2):91-97. PubMed ID: 12496845
    [Abstract] [Full Text] [Related]

  • 35. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
    Wan XS, Xu YA, Ware JH, Kennedy AR.
    Prostate; 2003 Jul 01; 56(2):131-41. PubMed ID: 12746838
    [Abstract] [Full Text] [Related]

  • 36. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.
    Christensson A, Björk T, Nilsson O, Dahlén U, Matikainen MT, Cockett AT, Abrahamsson PA, Lilja H.
    J Urol; 1993 Jul 01; 150(1):100-5. PubMed ID: 7685416
    [Abstract] [Full Text] [Related]

  • 37. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays.
    Zhou AM, Tewari PC, Bluestein BI, Caldwell GW, Larsen FL.
    Clin Chem; 1993 Dec 01; 39(12):2483-91. PubMed ID: 7504592
    [Abstract] [Full Text] [Related]

  • 38. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
    Yonou H, Horiguchi Y, Ohno Y, Namiki K, Yoshioka K, Ohori M, Hatano T, Tachibana M.
    Prostate; 2007 Jun 01; 67(8):840-8. PubMed ID: 17394194
    [Abstract] [Full Text] [Related]

  • 39. Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer.
    Noldus J, Chen Z, Stamey TA.
    J Urol; 1997 Oct 01; 158(4):1606-9. PubMed ID: 9302183
    [Abstract] [Full Text] [Related]

  • 40. Measurement of prostate-specific antigen in serum using four different immunoassays.
    Cattini R, Robinson D, Gill O, Jolley N, Bacarese-Hamilton T.
    Eur J Clin Chem Clin Biochem; 1994 Mar 01; 32(3):181-5. PubMed ID: 7518258
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.